Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05103358 |
|---|---|
| Brief Title: | Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1) |
| First Submitted : | October 22, 2021 |
| First Submitted that Met QC Criteria : | October 22, 2021 |
| First Posted : | November 2, 2021 |
| Last Update Submitted that Met QC Criteria : | March 12, 2024 |
| Last Update Posted : | March 13, 2024 |